Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 28;2023(1):hoac053. doi: 10.1093/hropen/hoac053

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 3. — hUC-PRP immunocompatibility. Concentration of (A) IL-5, (B) IL-6, (C) TNFa and (D) IFNg in murine plasma collected 14 days following administration of saline, hUC-PRP or EndoECM + hUC-PRP, or a sham intervention, n = 5 per group. Data are presented as a mean of three replicates ± SD. P < 0.05. EndoECM, decellularized porcine endometrium-derived extracellular-matrix hydrogel; hUC-PRP, platelet-rich plasma from hUC; IFNg, interferon gamma; IL-5, interleukin 5; IL-6, interleukin 6; TNFa, tumor necrosis factor alpha.